| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/03/1997 | WO1997023504A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus |
| 07/03/1997 | WO1997023501A1 Therapeutic compositions |
| 07/03/1997 | WO1997023500A1 Endothelial cell proliferation inhibitor and method of use |
| 07/03/1997 | WO1997023244A1 Use of antisene oligodeoxynucleotides to produce truncated proteins |
| 07/03/1997 | WO1997023236A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 07/03/1997 | WO1997023129A1 Model transgenic animal for interleukin-1 relevant diseases |
| 07/03/1997 | CA2710777A1 Method for lysing cells |
| 07/03/1997 | CA2241364A1 Method and apparatus for conducting multiparametric fluorescence in situ hybridization |
| 07/03/1997 | CA2241139A1 Polyketide-associated sugar biosynthesis genes |
| 07/03/1997 | CA2241129A1 Therapeutic compositions |
| 07/03/1997 | CA2241105A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents |
| 07/03/1997 | CA2241023A1 Novel polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy |
| 07/03/1997 | CA2240968A1 Dna sequences coding for a protein conferring male sterility |
| 07/03/1997 | CA2240847A1 Process for propagation and/or selection of plant material |
| 07/03/1997 | CA2240832A1 A method for regulation of plant lignin composition |
| 07/03/1997 | CA2240739A1 A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 07/03/1997 | CA2240499A1 Size-based marker identification technology |
| 07/03/1997 | CA2239909A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 07/03/1997 | CA2239704A1 Polypeptides with interleukin 16 activity, process for the preparation and use thereof |
| 07/03/1997 | CA2239683A1 Homogeneous amplification and detection of nucleic acids |
| 07/03/1997 | CA2239682A1 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | CA2239303A1 Globins containing binding domains |
| 07/03/1997 | CA2238967A1 Antimicrobial proteins |
| 07/03/1997 | CA2238873A1 Cell activation process and reagents therefor |
| 07/03/1997 | CA2237543A1 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | CA2213512A1 Method for producing bioactive fusion protein |
| 07/02/1997 | EP0781849A1 Tissue-specific promoter |
| 07/02/1997 | EP0781848A2 Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein |
| 07/02/1997 | EP0781846A2 Treponema pallidum fused antigen and assay for anti-treponema pallidum antibodies using the same fused antigen |
| 07/02/1997 | EP0781845A2 Anti-human milk fat globule humanised antibodies and processes for their production |
| 07/02/1997 | EP0781844A1 Gene participating in apoptosis |
| 07/02/1997 | EP0781779A2 Nonantigenic stabilizer and physiologically active substance |
| 07/02/1997 | EP0781351A1 In vitro method for predicting the evolutionary response of hiv protease to a drug targeted thereagainst |
| 07/02/1997 | EP0781349A1 Decomposition of bacteria cells by phage lysins |
| 07/02/1997 | EP0781347A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 07/02/1997 | EP0781344A1 Novel implant and novel vector for the treatment of acquired diseases |
| 07/02/1997 | EP0781343A1 Retroviral vector hybrids and the use thereof for gene transfer |
| 07/02/1997 | EP0781342A1 Phytopathogenic dna virus resistant transgenic plants and seeds and methods for obtaining same |
| 07/02/1997 | EP0781341A1 Method for the production of recombinant proteins, plasmids and modified cells |
| 07/02/1997 | EP0781340A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 07/02/1997 | EP0781339A2 Process for producing polyhydroxylic fatty acids and recombinant bacterial strains for carrying out the process |
| 07/02/1997 | EP0781338A1 VACCINES CONTAINING BORRELIA BURGDORFERI OspG |
| 07/02/1997 | EP0781337A1 Humanised antibody to integrin chain beta-1 |
| 07/02/1997 | EP0781336A1 A human map kinase homolog |
| 07/02/1997 | EP0781335A1 Cloning and characterizing of genes associated with long-term memory |
| 07/02/1997 | EP0781334A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 07/02/1997 | EP0781333A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
| 07/02/1997 | EP0781332A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 07/02/1997 | EP0781331A1 Improvements in or relating to binding proteins for recognition of dna |
| 07/02/1997 | EP0781330A1 METHODS AND COMPOSITIONS FOR cDNA SYNTHESIS |
| 07/02/1997 | EP0781329A1 Overexpression of mammalian and viral proteins |
| 07/02/1997 | EP0781327A1 Production of hydroxylated fatty acids in genetically modified plants |
| 07/02/1997 | EP0781326A1 The irs family of genes |
| 07/02/1997 | EP0781297A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same |
| 07/02/1997 | EP0781296A1 ACTIVE INDUCTION OR PASSIVE IMMUNIZATION OF ANTI-gp48 ANTIBODIES AND ISOLATED gp48 PROTEIN |
| 07/02/1997 | EP0781295A1 Asp b1 insulin analogs |
| 07/02/1997 | EP0781293A1 Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides |
| 07/02/1997 | EP0781291A1 Process and device for isolating cellular substances such as nucleic acids from natural sources |
| 07/02/1997 | EP0781139A1 Intracellular delivery of chemical agents to a specific cell type |
| 07/02/1997 | EP0781095A1 Cells bearing cd4 decoy receptors and related molecules and methods |
| 07/02/1997 | EP0781092A1 Method of sensitizing tumor cells with adenovirus e1a |
| 07/02/1997 | EP0760012A4 Method of detecting compounds utilizing genetically modified lambdoid bacteriophage |
| 07/02/1997 | EP0739418B1 Methods of identifying lymphocytes with mutator phenotypes |
| 07/02/1997 | EP0702720A4 Method for defined deletions of dna |
| 07/02/1997 | EP0689552A4 A method of detecting rupture of the amniotic membranes in pregant mammals |
| 07/02/1997 | EP0686200A4 Amplification of nucleic acid sequences |
| 07/02/1997 | EP0627000A4 Mammalian expression systems for hcv proteins. |
| 07/02/1997 | EP0621871B1 A human kunitz-type protease inhibitor variant |
| 07/02/1997 | EP0592692B1 Fed batch process for protein secreting cells |
| 07/02/1997 | EP0575350A4 Method for culturing and transforming human stem cell-containing compositions |
| 07/02/1997 | EP0544713B1 Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 07/02/1997 | CN1153531A Expression of heterologous proteins in attenuated bacteria using HTRA-promoters |
| 07/02/1997 | CN1153530A Rheumatoid arthritis-related virus MSRV-1 and pathogenic and/or infective agent MSRV-2 |
| 07/02/1997 | CN1153529A Hepatitis G virus and molecular cloning thereof |
| 07/02/1997 | CN1153528A Pantropic neurotrophic factors |
| 07/02/1997 | CN1035304C Method and device for conversion of plant |
| 07/01/1997 | USH1662 Chemically modified lymphokine and production thereof |
| 07/01/1997 | US5644065 Having somataic and germ cells containing an inserted exogenous dna sequence which prevents gene expression of major histocompatibility complex |
| 07/01/1997 | US5644047 Compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection |
| 07/01/1997 | US5644046 Cloning of a gene encoding for the growth hormone releasing hormone receptor |
| 07/01/1997 | US5644036 Purified immunoglobulin |
| 07/01/1997 | US5644035 Method for purifying secreted Mac-2-binding glycoprotein |
| 07/01/1997 | US5644033 Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment |
| 07/01/1997 | US5644031 Delta-like gene expressed in neuroendocrine tumors |
| 07/01/1997 | US5644030 Gene and method for production of an IgA binding protein |
| 07/01/1997 | US5643890 Anticarcinogenic agents |
| 07/01/1997 | US5643877 Compounds comprising gonadotropin releasing hormone (GnRH) and methods for controlling reproduction in fish |
| 07/01/1997 | US5643792 Mutant strain of Pichia pastoris which utilizes methanol in the presence of glucose |
| 07/01/1997 | US5643790 Genetic engineering with coryneform bacterium |
| 07/01/1997 | US5643788 Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides |
| 07/01/1997 | US5643785 Polynucleotides encoding AMPA-binding human GluR4 receptors |
| 07/01/1997 | US5643781 DNA encoding protocadherin-42 |
| 07/01/1997 | US5643780 Compositions and methods for modulating RNA activity through modification of the 5' cap structure of RNA |
| 07/01/1997 | US5643779 Nucleic acid coding for an α-acetolactate synthase from lactococcus and its applications |
| 07/01/1997 | US5643778 RNA editing enzyme and methods of use thereof |
| 07/01/1997 | US5643776 Insect diagnostic and control compositions |
| 07/01/1997 | US5643774 Dna molecules with polypeptides formed by biosynthesis |
| 07/01/1997 | US5643770 Retroviral vector particles expressing complement inhibitor activity |
| 07/01/1997 | US5643768 Cell-free synthesis and isolation of novel genes and polypeptides |
| 07/01/1997 | US5643767 Process for isolating cellular components |